2000
DOI: 10.1002/1098-2825(2000)14:5<220::aid-jcla4>3.3.co;2-u
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy

Abstract: The levels of serum IgA and C3 in patients with IgA nephropathy were determined using international standard serum (IFCC/CRM470) in a multicenter trial in Japan. The ratio of serum IgA to C3 (serum IgA/C3 ratio) without any information from renal biopsy was used for the diagnosis of IgA nephropathy. Three hundred and six patients with IgA nephropathy and other glomerular diseases, and 418 healthy adults were examined. The new diagnostic standardized criterion in patients with IgA nephropathy, obtained by nephe… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
5
2
2
0

Citation Types

0
8
0
0

Year Published

Range
2001
2001
2026
2026

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations

Cited by 8 publications

(8 citation statements)
references

References 4 publications

0
8
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…These results are at variance with results reported by Komatsu et al for adult patients evaluated using the four-grade classification of the Special Study Group on Progressive Glomerular Disease. Their study showed significantly higher IgA/C3 ratio values in patients with more severe lesions (grade III-IV) compared with those with milder (grade I-II) lesion, with no significant differences in serum IgA and C3 levels between groups [13]. In our pediatric population, however, MEST score ≥ 3 was found significantly more frequently in patients with WHO grade III-IV lesions compared with those with grade I-II lesions.…”
Section: Discussion
mentioning
confidence: 60%